Stephens Inc’s Puma Biotechnology PBYI Stock Holding History

Stephens Inc’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-6,178	Closed	-$240K	–	1208
2019 Q1	$240K	Buy	+6,178	New	+$189K	0.01%	992
2018 Q4	–	Sell	-5,121	Closed	-$235K	–	1162
2018 Q3	$235K	Buy	+5,121	New	+$247K	0.01%	1002
2017 Q3	–	Sell	-4,500	Closed	-$393K	–	831
2017 Q2	$393K	Buy	+4,500	New	+$252K	0.01%	628
2016 Q4	–	Sell	-4,500	Closed	-$302K	–	818
2016 Q3	$302K	Buy	+4,500	New	+$228K	0.01%	611
2016 Q1	–	Sell	-4,500	Closed	-$353K	–	786
2015 Q4	$353K	Hold	4,500	–	–	0.02%	504
2015 Q3	$339K	Hold	4,500	–	–	0.02%	521
2015 Q2	$525K	Hold	4,500	–	–	0.02%	491
2015 Q1	$1.06M	Hold	4,500	–	–	0.05%	344
2014 Q4	$852K	Hold	4,500	–	–	0.04%	377
2014 Q3	$1.07M	Hold	4,500	–	–	0.05%	322
2014 Q2	$297K	Hold	4,500	–	–	0.02%	639
2014 Q1	$469K	Hold	4,500	–	–	0.03%	483
2013 Q4	$466K	Hold	4,500	–	–	0.02%	531
2013 Q3	$241K	Buy	+4,500	New	+$243K	0.01%	657

Other funds holding PBYI

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Stephens Inc's PBYI Position: Q2 2019 in Review

Stephens Inc sold out of Puma Biotechnology (PBYI) in Q2 2019, closing a stake of 6,178 shares — an estimated $240K sold.

Stephens Inc first reported a position in PBYI in Q3 2013 and held it in 14 quarters. The position peaked at $1.07M in Q3 2014. 139 funds tracked by Wall St. Rank hold PBYI as of Q2 2019.

Stephens Inc reported no remaining Puma Biotechnology position as of Q2 2019 after selling out during the quarter.
Stephens Inc sold 6,178 Puma Biotechnology shares in Q2 2019, an estimated $240K.
Stephens Inc first reported a position in Puma Biotechnology in Q3 2013 and held it in 14 quarters.
Stephens Inc's Puma Biotechnology position peaked at $1.07M in Q3 2014.
139 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2019.

Based on Stephens Inc's 13F filing for Q2 2019, filed 1 Aug 2019.